Pulsar Health is joining imc group with the full support of pan-European investor Waterland Private Equity. Located in Cheadle, North West England, Pulsar Health’s ethos and expertise prioritise a ‘one team’ approach to meet clients’ scientific and marketing objectives, making the company a natural partner for imc group. The partnership
A medtech start-up whose sensor technology could improve outcomes for patients having knee replacement operations has raised GBP1.4 million to bring its device to market. Eventum Orthopaedics has secured funding from NPIF – Mercia Equity Finance, which is managed by Mercia and is part of the Northern Powerhouse Investment Fund,
Ropes & Gray has advised NeoGenomics, Inc, a provider of cancer-focused genetic testing services and global oncology contract research services, on its acquisition – including its financing via private placement of equity – of Inivata Ltd, a global, commercial stage liquid biopsy platform company, headquartered in Cambridge, UK. The acquisition
Invizius Limited (Invizius), a biotechnology company developing treatments to suppress unwanted innate immune responses, has closed a Series A financing of GBP5.3 million. The round was led by existing investors Mercia, Downing Ventures, Old College Capital, Scottish Enterprise, Solvay Ventures and new investors Calculus Capital and experienced life science entrepreneur
Partners Group is to acquire Axia Women’s Health (Axia), a women’s healthcare provider in the US, from Audax Private Equity. Partners Group will become the majority equity holder, while Axia’s management team and physician partners will retain a substantial minority equity stake. Axia is headquartered in Voorhees, New Jersey,
Global private equity firm CVC Capital Partners (CVC) has acquired a majority interest in Health action company Icario, through the CVC Growth Partners II fund. Financial terms of the investment, which will be used to fuel Icario’s next phase of growth, have not been disclosed. Having rebranded earlier this
Arrowpoint Advisory has advised Ascenti Health (Ascenti), a technology-led disruptor in the UK physiotherapy and mental wellbeing markets, on its sale to bd-capital partners (bd-capital). Ascenti started in 1996 as a small rehabilitation business helping victims of motor accidents recover from injury, and through organic growth and a series of
Mogrify Limited (Mogrify), a biopharmaceutical company aiming to transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies, has held the second closing of its Series A financing of USD17 million, bringing the total raised to USD33 million in this round. The funding
EW Healthcare Partners (EW) has acquired a majority stake in Laboratoires Majorelle (Majorelle) from its Founders to support its growth and European expansion in line with the Founders’ strategy.
24 October, 2024 – 8:30 am
14 November, 2024 – 8:00 am
16 May, 2024 – 5:30 pm
13 March, 2024 – 6:00 pm
